FOCUSED ON PEOPLE, DRIVEN BY RESEARCH
At Quiet Waters Health, our goal is to change the way healthcare is practiced on a global level through hormone optimization and precision and preventative medicine. This approach is deeply rooted in our dedication to scientific and clinical research. To share these developments, we maintain an evolving selection of peer-reviewed white papers and studies.
A Call for More Voices on Hormone Optimization
Originally developed in 1939 for women who underwent radical hysterectomies—and widely used in Europe and Australia—compounded bio-identical hormone pellet therapy is the longest studied form of hormone replacement therapy to date. But more study is needed to build confidence within the scientific community and to increase access, as appropriate, to a broader continuum of options for patients.
Quiet Waters Health seeks to be a leading industry voice for hormone optimization quality and access to information. Human hormones are inherently idiosyncratic, which means that patients need personalized, compounded solutions that offer more flexibility and accessibility than other forms of hormone therapy can offer. We are calling for more clinical research in the often misconstrued and underutilized field of hormone therapy and working to produce our own contributions to this burgeoning field by sharing our results gained from more than 2.5 million pellet insertions in just over a decade. Recognizing a wide gap exists in formal clinical research and education, Quiet Waters Health gathers experiential insights to inform the direction of clinical research and confirm with science the real-world data that patients experience.
Our Research Commitment
Quiet Waters Health is a company dedicated to clinical research for hormone optimization. Learn more about our most recent research projects below.
Breast Cancer Study
9-year retrospective review
To demonstrate testosterone is breast protective, particularly when delivered by subcutaneous pellet therapy, T and/or Testosterone/ Estradiol delivered subcutaneously as a pellet implant significantly reduced the incidence of breast cancer in pre-and – post-menopausal women.*
Complication Study
9-year retrospective review
To demonstrate testosterone is breast protective, particularly when delivered by subcutaneous pellet therapy, T and/or Testosterone/ Estradiol delivered subcutaneously as a pellet implant significantly reduced the incidence of breast cancer in pre-and – post-menopausal women.*
.png)
Title goes here
Title goes here
Title goes here
Title goes here
Title goes here
Heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce ut elementum elit. Nulla pharetra sem id nisi ornare, eget porta eros vehicula. Morbi vel nisl finibus, porta lacus eget, lobortis enim.
Heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce ut elementum elit. Nulla pharetra sem id nisi ornare, eget porta eros vehicula. Morbi vel nisl finibus, porta lacus eget, lobortis enim.